Zoom the image with the mouse
ToMORROW Cephapirin Benzathine for Dry Cow Mastitis Treatment - 10ml
SKU:
115063
UPC:
FTD304161
$5.99
ToMORROW prescription intramammary antibiotic gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.
Features
- ToMORROW has been an effective prolonged therapy treatment for more than 25 years
- ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains
- ToMORROW is formulated with cephapirin benzathine to provide broad-spectrum and long-acting therapy that dry cows need
Partial Insertion Reduces New Infections
- With the Opti-Sert applicator tip, partial insertion reduces the incidence of new infections during the dry period
- Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent
Dosage Information
Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.
Safety Information
Tomorrow should be administered with caution to subjects which have demonstrated some form of allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your veterinarian.
Residue Warnings
- For use in dry cows only
- Not to be used within 30 days of calving
- Milk from treated cows must not be used for food during the first 72 hr after calving
- Any animal infused with this product must not be slaughtered for food until 42 days after the latest infusion
Top Reasons To Use
- A recent head-to-head study conducted on six dairy farms in four states shows less than 5 percent of all dry cow mastitis pathogens at dry-off were gram-negative
- First-generation cephalosporins continue to maintain high effectiveness against gram-positive organisms and are more effective against those pathogens than third-generation cephalosporins
- Head-to-head study showed no difference in efficacy between the leading dry cow mastitis tubes
- Authors of the study concluded that "Due to the lack of difference in efficacy, other factors should be used in the consideration of dry cow mastitis treatment, including prudent use of antibiotics, withhold times and value"
Specifications
- Color: White to Yellow
- Size: 10ml
- Form: Liquid
- Certification: FDA
ToMORROW prescription intramammary antibiotic gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.
Features
- ToMORROW has been an effective prolonged therapy treatment for more than 25 years
- ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains
- ToMORROW is formulated with cephapirin benzathine to provide broad-spectrum and long-acting therapy that dry cows need
Partial Insertion Reduces New Infections
- With the Opti-Sert applicator tip, partial insertion reduces the incidence of new infections during the dry period
- Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent
Dosage Information
Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.
Safety Information
Tomorrow should be administered with caution to subjects which have demonstrated some form of allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your veterinarian.
Residue Warnings
- For use in dry cows only
- Not to be used within 30 days of calving
- Milk from treated cows must not be used for food during the first 72 hr after calving
- Any animal infused with this product must not be slaughtered for food until 42 days after the latest infusion
Top Reasons To Use
- A recent head-to-head study conducted on six dairy farms in four states shows less than 5 percent of all dry cow mastitis pathogens at dry-off were gram-negative
- First-generation cephalosporins continue to maintain high effectiveness against gram-positive organisms and are more effective against those pathogens than third-generation cephalosporins
- Head-to-head study showed no difference in efficacy between the leading dry cow mastitis tubes
- Authors of the study concluded that "Due to the lack of difference in efficacy, other factors should be used in the consideration of dry cow mastitis treatment, including prudent use of antibiotics, withhold times and value"
Specifications
- Color: White to Yellow
- Size: 10ml
- Form: Liquid
- Certification: FDA
Related Products
